Aruma is a Sydney, Australia-based company licensed by the Office of Drug Control for the cultivation, manufacture, and supply of medicinal cannabis.
At Aruma our mission is to improve patient quality of life.
We develop, produce and distribute high quality, standardised cannabinoid-based therapeutics to treat unmet medical needs. We aim to inspire hope and deliver therapeutic benefits for patient’s seeking safe, reliable alternative treatment options where traditional therapies have fallen short.
We offer education and on-going support to healthcare practitioners, providing a simple way to prescribe our range of products and tailor medicinal cannabis therapies to meet individual patient needs.
Quality first, always.
All Aruma medicinal cannabis products are produced in accordance with Good Manufacturing Practices (GMP) and pass through a rigorous QA program which includes independent, third-party testing to strict Australian pharmaceutical standards, including Therapeutic Goods (Standard for Medicinal Cannabis) (THO 93) Order 2017.
Research and Innovation
At Aruma, we seek to advance the science behind medicinal cannabis by undertaking and supporting research and development programs into the therapeutic effects of novel cannabinoid formulations and delivery mechanism.
We are a licensed, independent Australian biopharmaceutical company, driven by a passion for helping others. Quality and patient care are our first priorities, and we continuously seek to develop products and solutions to support positive health outcomes and treat unmet medical needs.